The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated Atopic Dermatitis treatment pathway

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) approve the use of baricitinib for the treatment of moderate to severe atopic dermatitis in line with NICE TA681. 

Baricitinib for this indication will be considered as RED on the traffic light status (treatment should be initiated and continued by specialist clinicians). 

Primary care prescriber should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.